Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenecteplase in Medium Vessel Occlusion for Acute Ischemic Stroke
NCT07047014Phase 3Recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Jul 2025
- Primary completion
- Mar 2027
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of tenecteplase in ischemic stroke, sponsored by Beijing Tiantan Hospital. Started Jul 2025; status: recruiting.
02
Drugs
tenecteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07047014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07047014.